Scientists at the University of California, San Francisco have uncovered a biological pathway that explains why staying active keeps the mind sharp. Their research indicates that physical activity fortifies the brain’s own protective mechanisms, making it more resilient to age‑related wear and tear.
With advancing age, the blood‑brain barrier – a dense network of vessels that normally blocks harmful substances – tends to become porous. When this barrier leaks, toxic molecules can enter brain tissue, sparking inflammation that contributes to cognitive decline and diseases such as Alzheimer’s.
Earlier work from the same group showed that exercising mice released larger amounts of a liver enzyme called GPLD1, which appeared to rejuvenate brain function. The puzzle was that GPLD1 itself cannot cross the blood‑brain barrier, leaving scientists unsure how it could exert its benefits.
GPLD1’s Role in Cleaning Up the Barrier
New experiments reveal that GPLD1 targets another protein, TNAP, that accumulates on the surface of barrier cells as animals age. Excess TNAP weakens the barrier, making it leakier. When mice run, their livers pump GPLD1 into the bloodstream; the enzyme then reaches the vessels surrounding the brain and trims away TNAP, helping to restore barrier integrity.
"This discovery highlights how the rest of the body influences brain aging," explains Dr. Saul Villeda of the UCSF Bakar Aging Research Institute.
Why TNAP Matters for Memory
To pinpoint GPLD1’s effect, researchers screened proteins that might serve as substrates for the enzyme. Among several candidates, only TNAP was effectively cleaved by GPLD1 in laboratory tests.
Further studies showed that young mice engineered to overproduce TNAP in the barrier exhibited memory deficits similar to those seen in older animals. Conversely, lowering TNAP levels in two‑year‑old mice – roughly equivalent to a 70‑year‑old human – tightened the barrier, cut inflammation, and improved performance on learning tasks.
Potential Paths for Alzheimer’s Therapies
These findings suggest that drugs designed to remove or inhibit proteins like TNAP could help rebuild a compromised blood‑brain barrier, even after it has deteriorated with age.
"We’re shedding light on a piece of brain aging that Alzheimer’s research has largely missed," says Villeda. "Targeting the barrier could open new therapeutic avenues beyond the classic brain‑centric approaches."